Originally Aired: January 18, 2023
Time: 8:00 am PT, 11:00 am ET, 17:00 CET



2022 saw a surge of interest and competition in the next-gen sequencing (NGS) industry, as established companies were joined by a hungry group of new platforms.

Today, researchers who sequence DNA have choices that they simply have not had before.

On this episode of GEN Live, we’ll talk about genomics—as a tool and as a field. Where is it now and what type of research is NGS enabling? We’ll also get into the crowded NGS market—considering the recent announcements of new technologies, instruments, and companies in this space. What will it take for the new companies to compete? We’ll also touch on other questions, such as: is long-read sequencing poised to overtake the utility of short reads?  

Julianna LeMieux, PhD

GEN Live logo


A live Q&A session followed the presentation, offering a chance to pose questions to our expert panelists.

Element Bio logo

Catharine Aquino
Catharine Aquino
Group Leader, Genomics Analytics
Functional Genomics Center Zurich

Michael Snyder
Michael Snyder, PhD
Chair, Dept. of Genetics
Director, Center for Genomics and Personalized Medicine
Stanford University School of Medicine